The Global Market for Biotechnology Instrumentation is Projected to Reach US$53.3 Billion by 2022

Expanding Biotech Research at the Back of Robust New Drug Development Activity to Drive the Biotechnology Instrumentation Market, According to a New Report by Global Industry Analysts, Inc.

GIA launches comprehensive analysis of industry segments, trends, growth drivers, market share, size and demand forecasts on the global Biotechnology Instrumentation market. The global market for Biotechnology Instrumentation is projected to reach US$53.3 billion by 2022, driven by the robust R&D investments in new drug development, enhancements in performance of existing technology platforms, and conceptualization of new measurement and instrument configuration systems.

Biotechnology has evolved into a wide and diverse industry over the years having undergone a transition from mere application of cultured microorganisms and animal and plant breeding processes to an advanced industry involving the use of various scientific and engineering disciplines. Today, biotechnology has become an important part of virtually every sector of the economy including chemical, agrochemical, beverage, food processing, healthcare, forensics, agriculture environmental monitoring, and animal husbandry, among others. The pharmaceuticals industry is the principal force driving the biotechnology revolution, primarily due to constant exploration for new drugs. Biotechnology instruments and tools are used in universities and pharmaceutical company research labs for cellular and molecular examination. Analytical instruments such as centrifuges, DNA synthesizers, protein analyzers and bio robotics are used by research laboratories in universities, and biotechnology and pharmaceutical companies. Over the years use of bioinstrumentation techniques has become simple and more accessible.

Demand for faster and economical ways to produce drugs for the pharmaceutical industry, proteomics, genomics, functional genomics and combinatorial chemistry have led to the advancements of bioinstrumentation in recent years. In addition to the human genome project that created ripples in the areas of proteomics and genomics, the market is also driven by considerable enhancements in performance of prevailing technology platforms, and conceptualization of new measurement and instrument configuration systems. Continuous advancements promise growth opportunities in clinical diagnostics, life sciences research, and personalized medicine. The evolution of Next-Generation Sequencing (NGS) technology has resulted in development of advanced molecular tools to facilitate the profiling the transcriptome and aid in the detection and analysis of noncoding RNA to understand cancer biology and create new therapeutic targets for cancer. The industry is expected to gain from expanding research and breakthroughs in areas such as molecular biology, next generation sequencing, and bioinformatics to analyze and interpret information at molecular level.

As stated by the new market research report on Biotechnology Instrumentation, the United States represents the largest market worldwide. Asia-Pacific is forecast to record the fastest CAGR of 9.5% over the analysis period led by robust growth from the Chinese and Indian markets. Growing population, rising per capita income, increasing government spending and increasing focus on research and development activity are the major factors contributing to the growth in the region.

Major players in the market include Abbott Laboratories, Agilent Technologies Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Bruker Corporation, GE HealthCare, Gilson Inc., Harvard Bioscience Inc., Hitachi High-Technologies Corp., Illumina Inc., Lonza Group AG, PerkinElmer Inc., Roche Diagnostics, Shimadzu Corp., Siemens Healthineers, Thermo Fisher Scientific Inc., and Waters Corp. among others.

The research report titled “Biotechnology Instrumentation: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities of global companies. The report provides market estimates and projections in value terms for all major geographic markets such as the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia and Rest of Europe), Asia-Pacific (China, India and Rest of Asia-Pacific), Latin America (Brazil, Mexico and Rest of Latin America) and Rest of World. Product segments analyzed include DNA Sequencing Systems, DNA Synthesizers, Electrophoresis Systems, Immunoassay Systems, Laboratory Automation, Liquid Chromatography Systems, Mass Spectrometry, MicroArrays, and Protein/Peptide Synthesizers.

For enquiries e-mail us at rsd@strategyr.com or info411@strategyr.com.

To connect with us, visit our LinkedIn page.

Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.